We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

March 23, 2011

PAR PHARMACEUTICAL, INC. v. UCB, INC. et al

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. August 24, 2011

    Par, UCB Pharma Settle Keppra Patent Fight

    UCB Pharma SA and Par Pharmaceutical Inc. on Monday settled a suit Par had filed in Pennsylvania seeking a court declaration that two UCB patents were invalid and not infringed by Par's proposed generic version of the epilepsy drug Keppra.

1 other articles on this case. View all »

Parties

To view the parties, register now.